BioAgilytix

BioAgilytix is a global contract research organization (CRO) that specializes in bioanalytical services for biologics. With over 30 years of collective expertise, the company supports drug development across preclinical, clinical, and commercial stages, ensuring regulatory compliance and data integrity. BioAgilytix has received recognition as a Triangle Business Journal Fast 50 Award recipient in 2024 and has been named to the Inc. 5000 list of fastest-growing private companies multiple times. The company offers a range of services, including custom assay development and validation, high-quality sample analysis, regulatory support, quality control testing, and diagnostic testing through its CLIA-certified, CAP-accredited laboratory in Boston. BioAgilytix serves leading global pharmaceutical and biotechnology companies, focusing on large-molecule therapies in various therapeutic areas such as oncology and immunology. With laboratories in multiple locations, including the U.S. and Germany, BioAgilytix is well-equipped to support global clinical trials and regulatory needs.